Biogen’s tau targeting Alzheimer’s disease therapy gets FDA Fast Track status
Biogen ( NASDAQ: BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...
Biogen announces U.S. FDA granted Fast Track designation to BIIB080
Biogen (BIIB) announced that the U.S. Food and Drug Administration, FDA, has granted Fast Track designation to BIIB080, an investigational ...
Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease
Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
Biogen's BIIB080 Gets FDA Fast-Track Designation in Alzheimer's Disease
Biogen on Wednesday said BIIB080 is the first tau-targeting antisense oligonucleotide therapy to enter clinical development for Alzheimer's disease and that it is currently being evaluated in a global ...
Organon acquires Actemra biosimilar’s US rights from Biogen
Bio-Thera Solutions, the developer of the biosimilar, will continue to hold manufacturing rights in the US market.
PharmExec4h
FDA Grants Fast Track Designation to Biogen’s Novel Alzheimer Disease Drug Candidate
BIIB080 marks the first antisense oligonucleotide targeting tau to enter clinical development for the treatment of Alzheimer ...
Pharmabiz10h
Eisai & Biogen update on regulatory review of MAA for lecanemab for early Alzheimer’s disease by the European Commission
Eisai & Biogen update on regulatory review of MAA for lecanemab for early Alzheimer’s disease by the European Commission: Tokyo Wednesday, April 2, 2025, 16:00 Hrs [IST] Eisai C ...
Barchart on MSN23h
Stocks Finish Higher as Magnificent Seven Stocks Rally
Tuesday closed up +0.38%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.03%, and the Nasdaq 100 Index ($IUXX) ...
US open: Stocks lower ahead of tariff announcement
Major indices were in the red at the opening bell as investors patiently awaited Donald Trump's so-called 'Liberation Day' ...
US close: Stocks mostly higher as traders await 'Liberation Day' tariff announcements
Major indices were mostly higher at the close on Tuesday as investors digested a report from the Washington Post that the ...